Company Filing History:
4 out of 143 
1 out of 167 Years Active: 2002-2016
Title: The Innovations of Robert Ian Lechler
Introduction
Robert Ian Lechler is a prominent inventor based in London, GB. He has made significant contributions to the field of biomedical engineering, particularly in the area of organ transplantation and immunology. With a total of five patents to his name, Lechler's work focuses on innovative solutions to enhance organ acceptance and reduce rejection rates.
Latest Patents
One of Lechler's latest patents is the "Anticoagulant fusion protein anchored to cell membrane." This invention relates to the inhibition of blood coagulation, especially during organ rejection. It provides anticoagulant proteins that are anchored to cell membranes, which are regulated according to cell activation. This innovation aims to make cells, tissues, and organs less vulnerable to rejection after transplantation. Another significant patent is "Porcine CTLA-4 for xenograft-specific immunosuppression." This invention offers methods for inhibiting T-cell mediated rejection of a xenotransplanted organ by blocking the delivery of co-stimulatory signals. It presents various approaches to prevent the activation of xenoreactive T-cells in the recipient.
Career Highlights
Throughout his career, Robert Ian Lechler has worked with notable organizations, including Imperial College Innovations Limited and Imperial Innovations Limited. His work has been instrumental in advancing the understanding and application of immunosuppressive techniques in organ transplantation.
Collaborations
Lechler has collaborated with esteemed colleagues such as Anthony Dorling and Kristian Riesbeck. These partnerships have contributed to the development of innovative solutions in the field of transplantation and immunology.
Conclusion
Robert Ian Lechler's contributions to the field of biomedical engineering through his patents and collaborations highlight his commitment to improving organ transplantation outcomes. His innovative approaches continue to pave the way for advancements in medical science.